clinical trial · NCT01519882
Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease
UCB Pharma SA·phase4·terminated·n = 1
Advanced Idiopathic Parkinson's DiseasePlaceboRotigotine
brief summary
This is a phase 4 study to evaluate with Polysomnography (PSG) and subjective measures the effect of Rotigotine on sleep efficiency, maintenance, insomnia, nocturnal akinesia and night-time movement in bed, in patients with advanced Parkinson's disease.
started
Mar 1, 2012
primary completion
Dec 1, 2012
completion
Jan 1, 2013
last updated
Apr 3, 2025
official title
A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Effects of Rotigotine on Sleep Efficiency in Patients With Advanced Parkinson's Disease.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol